In a dermal sensitization study (MRID [number]) with [chemical name (% a.i).] in (name of vehicle if appropriate), (young adult) (strain) (species) (#/sex) were tested using the method of (cite study type). (Very briefly describe method if necessary, however, citation may often be enough.) Identify positive control material. List clinical signs (systemic and local for LLNA) and mortality. Necropsy results for LLNA if significant.
(Very briefly note severity and duration of sensitization/ irritation. In this study, Chemical X is (not) a dermal sensitizer [include qualifiers such as moderate or slight if joint review with EPA]. Label comment if applicable.